-
Uncategorized2 weeks ago
Biotechs Must Face Reality To Succeed in Today’s Funding Environment
The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people think.
-
Uncategorized2 weeks ago
Japan’s Drug Prices Are Creating Problems for Washington and Tokyo Alike
If the U.S. can help Japan reform its drug pricing controls, both countries stand to benefit.
-
Uncategorized2 weeks ago
‘Zombie cells’ return from the dead — after a genome transplant
Post Content
-
Uncategorized2 weeks ago
Tang Seizes Control of Aurinia, Taking CEO Post in Total Transformation of C-Suite
Healthcare investor Kevin Tang and his allies now hold almost every leadership position at Aurinia Pharmaceuticals, the company at the heart of former CDER Director George...
-
Uncategorized2 weeks ago
Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint
The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% efficacy against the tick-borne disease in a...
-
Uncategorized2 weeks agoRoche leads AI drug discovery with new NVIDIA deal
Roche now operates the pharmaceutical industry’s largest announced hybrid-cloud AI factory, totalling more than 3,500 GPUs, following an expansion of its global AI infrastructure. The company...
-
Uncategorized2 weeks agoEMA launches tools to accelerate development of medicines
The European Medicines Agency (EMA) has launched three major new features of PRIME, the Agency’s scheme to enhance support for the development of medicines targeting an...
-
Uncategorized2 weeks ago
Sanofi Keeps Immuno Deals Coming With Kali Bet Worth Potential $1B+
Kali Therapeutics’ T cell engager, for which Sanofi is initially paying $180 million, could potentially be developed for a range of B cell–driven autoimmune disorders.
-
Uncategorized2 weeks ago
FDA Warns of Seizure Risk With Some Parkinson’s Drugs
The FDA detected 14 cases of vitamin B6 deficiency–linked seizures and two deaths in patients with Parkinson’s disease taking carbidopa/levodopa drugs. Both AbbVie and Novartis market...
-
Uncategorized2 weeks ago
Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design
Earendil Labs’ AI-centered platform has produced more than 40 programs, including anti-inflammatory assets that have attracted a pair of partnership agreements with Sanofi.
BioNTech to shutter Singapore HQ after ‘comprehensive review’
STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say
